Aredia Judge Tosses More Failure-To-Warn Claims
By Christine Caulfield · November 25, 2008, 12:00 AM EST
Novartis Pharmaceuticals Corp. has prevailed again in its ongoing bid to get failure-to-warn claims tossed from cases in the multidistrict litigation over its bone cancer drugs Aredia and Zometa....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login